Best Practice & Research in Clinical Rheumatology

Papers
(The H4-Index of Best Practice & Research in Clinical Rheumatology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The importance of functional genomics studies in precision rheumatology150
Editorial Board67
Rehabilitation interventions in osteoarthritis60
Employment outcomes in systemic sclerosis60
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit50
Possible future avenues for myositis therapeutics: DM, IMNM and IBM45
Change of the microvascularization in systemic sclerosis, a matter of air42
Update of imaging in the assessment of axial spondyloarthritis36
Novel therapies – IMID Co-morbidities34
Rheumatic manifestations of HIV/AIDS32
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus32
Epidemiology of rheumatic diseases in tropical populations32
The inequity of global healthcare in pediatric rheumatology28
Environmental factors and rheumatic diseases27
Novel therapies in Sjögren’s disease: A systematic review of the literature26
Pathophysiology and immunolgical basis of axial spondyloarthritis25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases24
The microbiome and systemic sclerosis: A review of current evidence22
Index for PART A22
Osteoporosis in 2022: Care gaps to screening and personalised medicine22
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis22
The role of calcium crystals and their effect on osteoarthritis pathogenesis22
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus22
0.25077700614929